Literature DB >> 27501398

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain.

Hideya Kawasaki1, Isao Kosugi2, Makiko Sakao-Suzuki3, Shiori Meguro2, Yoshihiro Tsutsui4, Toshihide Iwashita2.   

Abstract

In the study on the pathogenesis of viral encephalitis, the infection method is critical. The first of the two main infectious routes to the brain is the hematogenous route, which involves infection of the endothelial cells and pericytes of the brain. The second is the intracerebroventricular (ICV) route. Once within the central nervous system (CNS), viruses may spread to the subarachnoid space, meninges, and choroid plexus via the cerebrospinal fluid. In experimental models, the earliest stages of CNS viral distribution are not well characterized, and it is unclear whether only certain cells are initially infected. Here, we have analyzed the distribution of cytomegalovirus (CMV) particles during the acute phase of infection, termed primary viremia, following ICV or intravascular (IV) injection into the neonatal mouse brain. In the ICV injection model, 5 µl of murine CMV (MCMV) or fluorescent microbeads were injected into the lateral ventricle at the midpoint between the ear and eye using a 10-µl syringe with a 27 G needle. In the IV injection model, a 1-ml syringe with a 35 G needle was used. A transilluminator was used to visualize the superficial temporal (facial) vein of the neonatal mouse. We infused 50 µl of MCMV or fluorescent microbeads into the superficial temporal vein. Brains were harvested at different time points post-injection. MCMV genomes were detected using the in situ hybridization method. Fluorescent microbeads or green fluorescent protein expressing recombinant MCMV particles were observed by fluorescent microscopy. These techniques can be applied to many other pathogens to investigate the pathogenesis of encephalitis.

Entities:  

Mesh:

Year:  2016        PMID: 27501398      PMCID: PMC5091671          DOI: 10.3791/54164

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  26 in total

1.  Pandoraviruses: amoeba viruses with genomes up to 2.5 Mb reaching that of parasitic eukaryotes.

Authors:  Nadège Philippe; Matthieu Legendre; Gabriel Doutre; Yohann Couté; Olivier Poirot; Magali Lescot; Defne Arslan; Virginie Seltzer; Lionel Bertaux; Christophe Bruley; Jérome Garin; Jean-Michel Claverie; Chantal Abergel
Journal:  Science       Date:  2013-07-19       Impact factor: 47.728

2.  Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice.

Authors:  Jacqueline J Glascock; Erkan Y Osman; Tristan H Coady; Ferrill F Rose; Monir Shababi; Christian L Lorson
Journal:  J Vis Exp       Date:  2011-10-03       Impact factor: 1.355

3.  Intravenous injections in neonatal mice.

Authors:  Sara E Gombash Lampe; Brian K Kaspar; Kevin D Foust
Journal:  J Vis Exp       Date:  2014-11-11       Impact factor: 1.355

4.  Cutting sections of paraffin-embedded tissues.

Authors:  Andrew H Fischer; Kenneth A Jacobson; Jack Rose; Rolf Zeller
Journal:  CSH Protoc       Date:  2008-05-01

5.  Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia.

Authors:  Makiko Ohshima; Akihiko Taguchi; Hidetoshi Tsuda; Yoshiaki Sato; Kenichi Yamahara; Mariko Harada-Shiba; Mikiya Miyazato; Tomoaki Ikeda; Hidehiro Iida; Masahiro Tsuji
Journal:  Brain Dev       Date:  2014-07-14       Impact factor: 1.961

6.  Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.

Authors:  Marco A Passini; Deborah J Watson; Charles H Vite; Daniel J Landsburg; Alyson L Feigenbaum; John H Wolfe
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction.

Authors:  Ji-Yoen Kim; Stacy D Grunke; Yona Levites; Todd E Golde; Joanna L Jankowsky
Journal:  J Vis Exp       Date:  2014-09-15       Impact factor: 1.355

8.  Analysis of cardiomyocyte development using immunofluorescence in embryonic mouse heart.

Authors:  Lisa D Wilsbacher; Shaun R Coughlin
Journal:  J Vis Exp       Date:  2015-03-26       Impact factor: 1.355

9.  Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection.

Authors:  Makiko Sakao-Suzuki; Hideya Kawasaki; Taisuke Akamatsu; Shiori Meguro; Hiroaki Miyajima; Toshihide Iwashita; Yoshihiro Tsutsui; Naoki Inoue; Isao Kosugi
Journal:  Ann Clin Transl Neurol       Date:  2014-07-28       Impact factor: 4.511

10.  Murine cytomegalovirus displays selective infection of cells within hours after systemic administration.

Authors:  Kimberly M Hsu; Jennifer R Pratt; Walter J Akers; Samuel I Achilefu; Wayne M Yokoyama
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

View more
  3 in total

1.  Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1.

Authors:  Yoshie Kurokawa; Hitoshi Osaka; Takeshi Kouga; Eriko Jimbo; Kazuhiro Muramatsu; Sachie Nakamura; Yuki Takayanagi; Tatsushi Onaka; Shin-Ichi Muramatsu; Takanori Yamagata
Journal:  Hum Gene Ther       Date:  2021-02-22       Impact factor: 5.695

Review 2.  Adeno-associated virus (AAV)-based gene therapy for glioblastoma.

Authors:  Xin Xu; Wenli Chen; Wenjun Zhu; Jing Chen; Bin Ma; Jianxia Ding; Zaichuan Wang; Yifei Li; Yeming Wang; Xiaochun Zhang
Journal:  Cancer Cell Int       Date:  2021-01-26       Impact factor: 5.722

3.  Toxicity of internalized polyalanine to cells depends on aggregation.

Authors:  Yutaro Iizuka; Ryuji Owada; Takayasu Kawasaki; Fumio Hayashi; Masashi Sonoyama; Kazuhiro Nakamura
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.